Last10K.com

Oasmia Pharmaceutical Ab (OASM) SEC Filing 6-K Foreign Issuer report for the period ending Wednesday, March 6, 2019

Oasmia Pharmaceutical Ab

HISTORY TOOLS
CIK: 1607245 Ticker: OASM

View differences made from one to another to evaluate Oasmia Pharmaceutical Ab's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Oasmia Pharmaceutical Ab.

Continue

Assess how Oasmia Pharmaceutical Ab's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Oasmia Pharmaceutical Ab's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Oasmia Pharmaceutical Ab provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: OASM
CIK: 1607245
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001144204-19-012536
Submitted to the SEC: Wed Mar 06 2019 4:05:18 PM EST
Accepted by the SEC: Wed Mar 06 2019
Period: Wednesday, March 6, 2019
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/oasm/0001144204-19-012536.htm